Evidence map›Paper›PMID 38630334›Full record

ArticleCancer causes & control : CCC2024

Ambient polycyclic aromatic hydrocarbon exposure and breast cancer risk in a population-based Canadian case-control study.

Patrick Hinton, Paul J Villeneuve, Elisabeth Galarneau, Kristian Larsen, Deyong Wen, Jun Meng, Verica Savic-Jovcic, Junhua Zhang, Will D King

Open access · hybridAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Residential Proximity to NPL Superfund Sites and High Particulate Matter Exposure Is Associated with Increased Likelihood of Triple-Negative Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Patrick HintonDepartment of Public Health Sciences, Queen's University, Kingston, ON, Canada.ORCID http://orcid.org/0009-0006-8296-4680
Paul J VilleneuveDepartment of Neuroscience, Carleton University, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0001-7786-7997
Elisabeth GalarneauAir Quality Research Division, Environment and Climate Change Canada, Toronto, ON, Canada.
Kristian LarsenOffice of Environmental Health, Health Canada, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0003-1056-1867
Deyong WenAir Quality Research Division, Environment and Climate Change Canada, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-2682-2937
Jun MengAir Quality Research Division, Environment and Climate Change Canada, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-9716-1051
Verica Savic-JovcicAir Quality Research Division, Environment and Climate Change Canada, Toronto, ON, Canada.
Junhua ZhangAir Quality Research Division, Environment and Climate Change Canada, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-7973-9152
Will D KingDepartment of Public Health Sciences, Queen's University, Kingston, ON, Canada. kingw@queensu.ca.ORCID http://orcid.org/0009-0008-3474-1540
Environment and Climate Change Canada · CAQueen's University · CACarleton University · CAHealth Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePolycyclic aromatic hydrocarbons (PAHs) represent a class of ubiquitous pollutants recognized as established human carcinogens and endocrine-disrupting chemicals. PAHs have seldom been modeled at the population-level in epidemiological studies. Fluoranthene is a prevalent PAH in urban settings and correlates with the occurrence of other PAHs. The purpose of this study was to evaluate associations between long-term residential exposure to ambient PAHs and breast cancer risk, both pre- and post-menopausal, in Canada.

methodsUsing the National Enhanced Cancer Surveillance System (NECSS), a national-scale Canadian population-based case-control study, annual fluoranthene exposures were estimated using the GEM-MACH-PAH chemical transport model on the basis of geocoded residential histories throughout a 20-year exposure window. Odds ratios (ORs) and 95% confidence intervals (CIs) controlling for potential confounders were estimated using logistic regression. Separate analyses were conducted for Ontario and national samples given a finer-resolution exposure surface and additional risk factor information available for Ontario.

resultsPositive associations were observed between fluoranthene exposure and premenopausal breast cancer, with inconsistent findings for postmenopausal breast cancer. For premenopausal breast cancer, adjusted ORs of 2.48 (95% CI: 1.29, 4.77) and 1.59 (95% CI: 1.11, 2.29) were observed when comparing the second highest category of exposure to the lowest, among the Ontario and national samples, respectively. For postmenopausal breast cancer, adjusted ORs were 1.10 (95% CI: 0.67, 1.80) and 1.33 (95% CI: 1.02, 1.73). Associations for the highest level of exposure, across both samples and menopausal strata, were non-significant.

conclusionThis study provides support for the hypothesis that ambient PAH exposures increase the risk of premenopausal breast cancer.

Indexed as

Breast NeoplasmsEnvironmental ExposurePolycyclic Aromatic HydrocarbonsAdultAgedCanadaCase-Control StudiesFemaleFluorenesHumansMiddle AgedOdds RatioOntarioRisk FactorsFluorenesPolycyclic Aromatic HydrocarbonsAir pollutionBreast cancerCase–control studyPolycyclic aromatic hydrocarbons

Identifiers

PMID38630334
PMCPMC11266283
OpenAlexW4394873970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.